Mostrando resultados 21 a 40 de 202
< Anterior
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess |  | 2008 | Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma | San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria | artículo |
| closedAccess |  | 2014 | Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study | Morabito, Fortunato; Bringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio | artículo |
| closedAccess |  | 2009 | Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndromeMesenchymal stem cells of 5q− syndrome | López-Villar, Olga; García, Juan L. CSIC ORCID CVN ; Sánchez-Guijo, Fermín M. CSIC ORCID; Robledo, Cristina; Villarón, Eva M.; Díez-Campelo, María; Pérez-Simón, José A. CSIC ORCID; San Miguel, Jesús F. CSIC ORCID; Cañizo, María Consuelo del | artículo |
| openAccess |  | 1-nov-2010 | Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study | Lahuerta, Juan José; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2011 | Can multiple myeloma become a curable disease? | San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria | artículo |
| openAccess |  | 1-feb-2011 | CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell | Schmidt-Hieber, M.; Pérez-Andrés, Martin CSIC ORCID CVN; Paiva, Bruno; Flores-Montero, Juan; Gutiérrez, Norma Carmen; Matarraz, Sergio; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2012 | CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype | Paíno, Teresa CSIC ORCID; Ocio, Enrique M. CSIC ORCID ; Paiva, Bruno; San-Segundo, Laura CSIC; Garayoa, Mercedes CSIC ORCID ; Gutiérrez, Norma Carmen; Sarasquete, María Eugenia; Pandiella, Atanasio CSIC ORCID CVN ; Orfao, Alberto CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2008 | Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma | Lonial, Sagar; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2006 | Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vβ repertoire | Pérez-Andrés, Martin CSIC ORCID CVN; Almeida, Julia CSIC ORCID CVN; Martín-Ayuso, Marta; Mateo, Gema; San Miguel, Jesús F. CSIC ORCID; Orfao, Alberto CSIC ORCID | artículo |
| closedAccess |  | 2011 | Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating agents: Analysis of the VISTA trial | Richardson, Paul G.; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2014 | Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance | Thiago, Leandro S.; Pérez-Andrés, Martin CSIC ORCID CVN; Balanzategui, Ana; Sarasquete, María Eugenia; Paiva, Bruno; Jara-Acevedo, Maria; Bárcena, Paloma; Sánchez, Maria Luz; Almeida, Julia CSIC ORCID CVN; González, Marcos CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; García-Sanz, Ramón; Orfao, Alberto CSIC ORCID | artículo |
| closedAccess |  | 2013 | Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study | Martínez-López, Joaquín; García-Sanz, Ramón; Paiva, Bruno; Mateos, Maria Victoria; Sarasquete, María Eugenia; Bladé, Joan; San Miguel, Jesús F. CSIC ORCID; Lahuerta, Juan José | artículo |
| closedAccess |  | 2012 | Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients | Paiva, Bruno; Gutiérrez, Norma Carmen; Chen, Xi CSIC; Vidriales, Maria Belén; Martínez-López, Joaquín; Mateos, Maria Victoria; López-Corral, L.; Díaz-Rodríguez, Elena CSIC ORCID CVN; Orfao, Alberto CSIC ORCID ; Lahuerta, Juan José; Bladé, Joan; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2005 | Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment | Pérez-Andrés, Martin CSIC ORCID CVN; Almeida, Julia CSIC ORCID CVN; Martín-Ayuso, Marta; Mateo, Gema; San Miguel, Jesús F. CSIC ORCID; Orfao, Alberto CSIC ORCID | artículo |
| closedAccess |  | 2011 | Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma | Paiva, Bruno; Pérez-Andrés, Martin CSIC ORCID CVN; Almeida, Julia CSIC ORCID CVN; Mateos, Maria Victoria; López-Corral, L.; Gutiérrez, Norma Carmen; Schmidt-Hieber, M.; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Orfao, Alberto CSIC ORCID | artículo |
| closedAccess |  | 2010 | Concluding remarks and future directions | San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2011 | Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 | Rajkumar, S. Vincent; Richardson, Paul G.; Lonial, Sagar; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | dic-2021 | COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network | Ludwig, Heinz; Sonneveld, Pieter; Facon, Thierry; San Miguel, Jesús F. CSIC ORCID; Avet-Loiseau, Hervé; Mohty, Mohty, Mohamad; Mateos, Maria Victoria; Moreau, Philippe; Cavo, Michele; Pawlyn, Charlotte; Zweegman, Sonja; Engelhardt, Monika; Driessen, Christoph; Cook, Gordon; Dimopoulos, Meletios A.; Gay, Francesca; Einsele, Hermann; Delforge, Michel; Caers, Jo; Weisel, Katja C.; Jackson, Graham; Garderet, Laurent; Donk, Niels W. C. J. van de; Leleu, Xavier; Goldschmidt, Hartmut; Beksac, Meral; Nijhof, Inger; Schreder, Martin; Abildgaard, Niels; Hajek, Roman; Zojer, Niklas; Kastritis, Efstathios; Broijl, Annemiek; Schjesvold, Fredrik; Boccadoro, Mario; Terpos, Evangelos | artículo de revisión |
| closedAccess |  | 2000 | Cytogenetic abnormalities are associated with immunophenotypic changes in refractory anemias | Arroyo, J. L.; Hernández, Jesús M. CSIC ORCID ; Cañizo, María Consuelo del; Gutiérrez, Norma Carmen; González, M. Belén; García, Juan L. CSIC ORCID CVN ; Orfao, Alberto CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2013 | Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells | Schmidt-Hieber, M.; Gutiérrez, María Laura; Pérez-Andrés, Martin CSIC ORCID CVN; Paiva, Bruno; Rasillo, Ana; Tabernero, María D.; Sayagués, José María CSIC ORCID ; López, Antonio; Bárcena, Paloma; Sánchez, Maria Luz; Gutiérrez, Norma Carmen; San Miguel, Jesús F. CSIC ORCID; Orfao, Alberto CSIC ORCID | artículo |
